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Abstract The mysterious death of Mr. Alexander Lit-
vinenko who was most possibly poisoned by Polonium-210
(
210Po) in November 2006 in London attracted the attention
of the public to the kinetics, dosimetry and the risk of this
high radiotoxic isotope in the human body. In the present
paper, the urinary excretion of seven persons who were
possibly exposed to traces of
210Po was monitored. The
values measured in the GSF Radioanalytical Laboratory
are in the range of natural background concentration. To
assess the effective dose received by those persons, the
time-dependence of the organ equivalent dose and the
effective dose after acute ingestion and inhalation of
210Po
were calculated using the biokinetic model for polonium
(Po) recommended by the International Commission on
Radiological Protection (ICRP) and the one recently pub-
lished by Leggett and Eckerman (L&E). The daily urinary
excretion to effective dose conversion factors for ingestion
and inhalation were evaluated based on the ICRP and L&E
models for members of the public. The ingestion (inhala-
tion) effective dose per unit intake integrated over one day
is 1.7 · 10
–8 (1.4 · 10
–7)S vB q
–1, 2.0 · 10
–7 (9.6 · 10
–7)
Sv Bq
–1 over 10 days, 5.2 · 10
–7 (2.0 · 10
–6)S v B q
–1
over 30 days and 1.0 · 10
–6 (3.0 · 10
–6)S v B q
–1 over
100 days. The daily urinary excretions after acute ingestion
(inhalation) of 1 Bq of
210Po are 1.1 · 10
–3 (1.0 · 10
–4)o n
day 1, 2.0 · 10
–3 (1.9 · 10
–4) on day 10, 1.3 · 10
–3
(1.7 · 10
–4) on day 30 and 3.6 · 10
–4 (8.3 · 10
–5)B qd
–1
on day 100, respectively. The resulting committed effec-
tive doses range from 2.1 · 10
–3 to 1.7 · 10
–2 mSv by an
assumption of ingestion and from 5.5 · 10
–2 to 4.5 ·
10
–1 mSv by inhalation. For the case of Mr. Litvinenko, the
mean organ absorbed dose as a function of time was cal-
culated using both the above stated models. The red bone
marrow, the kidneys and the liver were considered as the
critical organs. Assuming a value of lethal absorbed dose of
5 Gy to the bone marrow, 6 Gy to the kidneys and 8 Gy to
the liver, the amount of
210Po which Mr. Litvinenko might
have ingested is therefore estimated to range from 27
to 1,408 MBq, i.e 0.2–8.5 lg, depending on the modality
of intake and on different assumptions about blood
absorption.
Introduction
Polonium-210 (
210Po) is a natural radionuclide which
decays to
206Pb, emitting alpha particles with energy of
5.3044 (100%) and 4.5166 MeV (0.00122%) [1]. The half-
life of
210Po is 138.376 days [1], which corresponds to a
speciﬁc activity of 1.66 · 10
14 Bq g
–1. High amounts of
pure
210Po activity can be produced by three ways: the
activation of
209Bi (natural abundance 100%) with thermal
neutrons (cross section r = 0.034 barn), the separation
from
222Rn daughter nuclides emanated from
226Ra, and
the separation from Pb–Bi alloy coolants of some fast
neutron reactors.
210Po is a decay daughter of
210Pb in
238U decay chain of
the uranium series; it occurs in the uranium ores and exists
ubiquitously in the environment. According to the United
Nations Scientiﬁc Committee on the Effects of Atomic
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210Po in
air is reported to be from 10 to 80 lBq m
–3 with a refer-
ence value of 50 lBq m
–3; the annual intake of the public
ranges from 18 Bq in South America to 220 Bq in Asia
with a reference value of 58 Bq. Through inhalation and
diet
210Po is accumulated in the human body, its concen-
tration in human tissues is 200 mBq kg
–1 in lungs,
600 mBq kg
–1 in liver, 600 mBq kg
–1 in kidneys,
100 mBq kg
–1 in muscle and other tissues, and
2,400 mBq kg
–1 in bone. However, these body contents are
reference values, they vary between individuals. The
presence of
210Po in tobacco greatly increases the intake of
this radionuclide by smokers. Recently, Desideri et al. [3]
reported that in Italy smokers who smoke 20 cigarettes per
day inhale, on average, 79.5 mBq of
210Po daily; those
smokers concomitantly inhale the same amount of radio-
activity from
210Pb. The measured
210Po concentration in
lung parenchyma of smokers is about three times that of
non-smokers [4]. Hill reported a higher content of
210Po in
kidneys, liver, lungs, and gonads for smokers compared to
non-smokers [5].
With regard to daily excretion, Glo ¨bel et al. [6] reported
in 1966 the measurements in one German subject to be in
the range of 40.7–351.5 mBq in feces and 2.2–37 mBq in
urine. Naumann et al. [7] reported daily urinary excretion
ranging from 2.8 (detection limit of 2 mBq l
–1 with urinary
excretion of 1.4 l d
–1) to 9.9 mBq d
–1 in Berlin area.
Dalheimer et al. [8] recently reported a daily urinary
excretion median value of 3.5 mBq d
–1 for non-smokers
and 6.6 mBq d
–1 for smokers. In Brazil, the reported values
of
210Po excretion in urine were 5.2 mBq l
–1 for non-
smokers and 9.8 mBq l
–1 for smokers [9, 10]. In Saudi
Arabia, the measured values range from 1.5 to 10 mBq l
–1
for non-smokers and 3.3 to 15.9 mBq l
–1 for smokers [11].
According to the model recommended by the Interna-
tional Commission on Radiological Protection (ICRP),
about 10–50% of ingested
210Po is absorbed by the intes-
tine and ﬂows into the bloodstream and mostly deposits in
the liver, kidneys, spleen, red bone marrow and other tis-
sues [12]. To distinguish between ingestion of the organic
and inorganic forms of polonium, ICRP recommended an
f1 value of 0.1 for workers and 0.5 for members of the
public [12]. For intake by inhalation, ICRP recommended
an f1 value of 0.1 for workers and members of the public
inhaling the material of Type F (fast absorption into blood)
and M (moderate absorption into blood) [13, 14], an f1
value of 0.01 was used for members of the public inhaling
the material of Type S (slow absorption into blood) [14].
The effective dose coefﬁcients of
210Po for adult members
of the public recommended by ICRP are 1.2 · 10
–6 Sv Bq
–1
for ingestion calculated with an f1 value of 0.5, and
3.3 · 10
–6 Sv Bq
–1 for inhalation assuming a material of
Type M with an f1 value of 0.1 [14].
As reported in the media, Mr. Alexander Litvinenko
died 23 days (the 23rd of November 2006 was included)
after he was possibly poisoned by
210Po. In this context, the
organ absorbed doses in the days following, say from
days 1 to 30, after acute intake of
210Po are important for
intake lethal dose estimation. The equivalent dose and
effective dose coefﬁcients are needed for the effective dose
and the risk assessments of other probably contaminated
members of the public.
In the present work, the daily urinary and fecal excre-
tions, the time-dependence of the equivalent dose and the
effective dose from 1 to 1,000 days after acute ingestion
and inhalation of 1 Bq of
210Po were calculated using the
biokinetic model for polonium recommended by ICRP [12]
and the model recently developed by Leggett and Ecker-
man (L&E) [15]. These modeled excretions and dose
coefﬁcients can be used for the estimate of intake and the
risk assessment, provided that the
210Po urinary or other
excreta data are available from the people who were
potentially contaminated in this
210Po accident. The GSF
Radioanalytical Laboratory measured urine samples of
seven German subjects who were suspected to have been
exposed to traces of
210Po in the aftermath of the poisoning
of Mr. Litvinenko. Those measured results and the calcu-
lated conversion factors of the daily urinary excretion to
effective dose are applied to assess the effective dose for
those persons. In order to estimate the possible intake of
210Po and organ dose for Mr. Litvinenko, the mean organ
absorbed dose was calculated applying the two above-
mentioned models. The results obtained using ICRP and
L&E models are compared and critically discussed.
Materials and methods
Experimental measurement of urinary excretion
of
210Po
Seven persons (5 male and 2 female) aged from 23 to
48 years from Germany provided their 24-h-urine samples
in December 2006. Among those persons only one was a
smoker. Information on the suspected day of exposure to
210Po was also acquired. Samples were measured between
6 and 12 days after the possible exposure. The complete
24-h-urine samples were transferred into appropriate glass
beakers. The sampling containers were washed twice with
20 ml 9 M HCl. The washing solutions were added to the
samples. About 160 mBq
208Po yield tracer and 1 g
ascorbic acid per liter urine were added. Polonium was
deposited onto copper discs (20 h, 20 C). The urine was
discarded and the discs were rinsed with water and iso-
propanole. The polonium isotopes were determined by
alpha spectrometry with Canberra PIPS detectors in
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123vacuum chambers. The spectra were evaluated with Euri-
sys Interwinner Software. The analytical procedure was
last validated by participating in the IAEA proﬁciency test
IAEA-CU-2007-09 on the determination of
210Po in water.
Biokinetic model of
210Po
The ICRP and L&E systemic biokinetic models of polo-
nium [12, 15], coupled with the gastrointestinal tract model
of ICRP Publication 30 [16] and the respiratory tract model
of ICRP Publication 66 [17], were used to calculate the
retentions of
210Po in organs or tissues after incorporation.
In the ICRP model, a fraction of 30, 10, 5, 10, and 45% of
polonium entering into the systemic circulation is deposited
in the liver, kidneys, spleen, red marrow and the rest of the
body, respectively. It is retained in those organs with a half-
life of 50 days. A ratio of 1:2 between the urinary and fecal
excretions isassumed forsystemic polonium[12].Recently,
an improved, physiologically realistic systemic biokinetic
model for polonium in humans was constructed by Leggett
and Eckerman based on the data identiﬁed to most likely
represent the typical behavior of polonium in laboratory
animals and human subjects [15]. In contrast to the current
ICRP model,the new proposedmodelenables onetopredict
the excretion of polonium in human hair and sweat. In
addition, a compartment representing the bone surface was
integrated into the model of polonium. The urinary excre-
tion pathway is more physiologically realistic than the
current ICRP model. Therefore, the new model is expected
to provide a more reliable estimation of the intake and the
effective dose from the measured urinary excretion data.
Dose calculation of
210Po after ingestion and inhalation
The average organ absorbed dose, DT, in an organ or a tissue
T, due to nuclear transformations, US, of a radionuclide in
various source organs S, is calculated applying the meth-
odology developed by the Medical Internal Radiation Dose
(MIRD) Committee [18]: DT ¼
P
s
~ AS   ST  S ðÞ ; where
~ AS is the time-integrated, or cumulated activity, and is equal
to the number of transformations US in S; S(T / S) is the
absorbed dose in T per unit cumulated activity in S. The
equivalent dose, HT, is given by summing the product of
US and the speciﬁc effective energy [SEE(T / S)] over all
source organs, S [19]. In the values of the speciﬁc effective
energy each type of radiation is weighted by a given radi-
ation weighting factor, which accounts for the different
effectiveness in inducing late effects.
The US of the radionuclide in the source organ or tissue
was obtained by integrating the retention function, which
was modeled by the SAAM II program (University of
Washington, Seattle, WA). The values of S(T / S) and
SEE(T / S) were calculated by using the SEECAL pro-
gram [20]. The effective dose, E, was calculated by the
sum of the product of the equivalent dose, HT and the
corresponding tissue weighting factor, wT, over 12 organs
and tissues (T) and the product between the equivalent dose
of the so called remainder tissue, Hrem, and its weighting
factor, wrem [19, 21]. The equivalent dose of the colon,
Hcolon, was calculated as 0.57 · HULI + 0.43 · HLLI,
where HULI and HLLI are the equivalent doses in the walls
of the upper large intestine (ULI) and the lower large
intestine (LLI), respectively [19]. The dose of thymus is
taken as a surrogate for the oesophagus, in absence of a
dosimetric model for the oesophagus [12]. For the lungs,
the apportionment factors for target cells in different lung
regions recommended by ICRP were used [17].
Results and discussion
Firstly, the measured
210Po urinary excretion is presented.
Secondly, the time-dependent organ equivalent dose,
effective dose, organ absorbed dose and daily excretion in
urine and in feces, in hair and sweat after acute ingestion
and inhalation of
210Po are shown. The average values of
body content and daily excretion of
210Po for the normal
unexposed public are estimated. Finally, the effective doses
for the possibly contaminated seven subjects are predicted.
The amount of
210Po Mr. Litvinenko probably ingested are
estimated and discussed based on different assumptions.
Measured
210Po urinary excretion
Figure 1 shows one alpha spectrum of the samples. The
208Po tracer contained some
209Po impurities. However,
this did not interfere with the determination of
210Po. In
Table 1, the
210Po activities (±1 combined standard
uncertainty) of seven 24-h-urine samples are shown. Daily
urinary excretion ranged from 3.3 to 26.4 mBq d
–1, with a
mean value of 11.3 mBq d
–1. All these values are in the
range of natural levels, and below the reported level of
30 mBq d
–1 set by the Health Protection Agency (HPA)
[22].
210Po organ equivalent dose and effective dose
after acute intake
The equivalent and effective doses per unit intake for
members of the public and for workers after acute ingestion
and inhalation using both the ICRP and L&E models are
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123presented in Fig. 2. The time-dependent equivalent and
effective doses incline to a constant value after 300 days of
acute intake. The effective dose coefﬁcient for inhalation is
generally higher than for ingestion. The organ equivalent
doses of public are higher than that of workers because the
f1 value of 0.5 recommended for the members of the public
is higher than the value of 0.1 for workers.
By inhalation, the total deposition of inhaled aerosols in
the whole respiratory tract for workers is 1.7 times higher
than that of the public. However, for workers, about 74% of
the total inhaled aerosols are assumed to be deposited in the
extrathoracic (ET) region, which gives less contribution to
the resulting dose coefﬁcient, in comparison to the public,
for which only 32% is assumed to be deposited in ET
region. The deposition in the alveolar–interstitial (AI)
region of the lungs for public is two times higher than that
for the workers [17]. Therefore, the dose coefﬁcient of the
lungs is higher for the public. This higher equivalent dose
in lungs makes a slightly higher effective dose for the
public.
For most organs, e.g. kidneys, liver, red marrow and
spleen, the organ equivalent dose calculated using the
ICRP model is generally higher than that by the L&E
model. By inhalation, the lung doses are the main contri-
bution to the effective dose and they are almost identical
between the two models. Anyway, the effective doses by
the two models show a smaller discrepancy than the change
in organ equivalent doses. For members of the public, the
effective dose coefﬁcients range from 1.7 · 10
–8 Sv Bq
–1
on the ﬁrst day, 2.0 · 10
–7 Sv Bq
–1 on the 10th day,
5.2 · 10
–7 Sv Bq
–1 on the 30th day, to a constant value of
1.2 · 10
–6 Sv Bq
–1 in the later days for acute ingestion;
and 1.4 · 10
–7, 9.6 · 10
–7, 2.0 · 10
–6, 3.3 · 10
–6 Sv Bq
–1
for acute inhalation on the same mentioned days with the
ICRP model, respectively.
210Po mean organ absorbed dose after acute intake
In order to assess deterministic effects of exposure to
210Po,
organ absorbed dose was also calculated. The time-
dependence of the organ absorbed dose after acute intake
of
210Po is shown in Fig. 3. Because
210Po is an alpha
emitter (negligible contribution to dose from gamma ray),
the organ absorbed doses are 20 times smaller than the
corresponding values of the organ equivalent dose since a
radiation weighting factor of 20 for alpha particles is
applied in calculating the organ equivalent dose. The
highest organ absorbed doses are in the kidneys after intake
for ingestion, and in the lungs after inhalation. Doses to
members of the public are generally higher than for
workers; the L&E model gives lower estimates than the
ICRP model. The dose absorbed by the red marrow per unit
ingestion (inhalation), calculated using the ICRP model for
members of the public, is 1.5 · 10
–3 (1.4 · 10
–4)G y
MBq
–1
at 1 day after incorporation, 2.2 · 10
–2 (2.1 · 10
–3)
Gy MBq
–1 at 10 days, 5.7 · 10
–2 (6.0 · 10
–3) Gy MBq
–1
at 30 days, and 1.1 · 10
–1 (1.5 · 10
–2) Gy MBq
–1 at
100 days, respectively.
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Fig. 1 Alpha spectrum of
208/209/210Po isolated from one 24-h-urine
sample.
209Po is an impurity of the
208Po tracer
Table 1
210Po activities (±1 combined standard uncertainty) of the 24-h-urine samples and the estimate of effective dose for the possible
contaminated persons
Subject
number
Volume of 24-h-urine
sample (l)
Measured daily
excretion (mBq d
–1)
Ingestion Inhalation Estimated amount (mBq)
E (mSv) E0 (mSv) E (mSv) E0 (mSv) Ingestion Inhalation
#1 0.92 4.5 ± 1.2 2.8E – 03 4.8E – 04 7.6E – 02 2.2E – 02 2.3 23.3
#2 3.35 10.8 ± 2.8 6.8E – 03 1.3E – 03 1.8E – 01 5.8E – 02 5.7 55.9
#3 2.74 12.4 ± 1.5 8.0E – 03 1.6E – 03 2.1E – 01 7.1E – 02 6.6 64.5
#4 1.50 9.5 ± 1.5 5.6E – 03 5.8E – 04 1.6E – 01 3.1E – 02 4.6 49.2
#5 2.25 12.4 ± 3.4 7.5E – 03 9.0E – 04 2.1E – 01 4.6E – 02 6.2 64.5
#6 2.01 3.3 ± 1.0 2.1E – 03 3.5E – 04 5.5E – 02 1.6E – 02 1.7 17.0
#7 3.42 26.4 ± 3.2 1.7E – 02 2.8E – 03 4.5E – 01 1.3E – 01 13.6 136.6
Mean 11.3
Median 10.8
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123210Po daily excretion in urine and in feces after acute
intake
The predicted daily excretions in urine and in feces, by
using both models, are shown in Fig. 4. The lower intestinal
absorption, assumed for the workers, results in a higher
value in their fecal excretions. For both the public and the
workers, the daily urinary and fecal excretions by ingestion
are much higher than that by inhalation. By means of the
L&E model, the excretion of
210Po in human hair and sweat
could be used to estimate the intake and the level of
210Po in
the human body, provided that the measured amount of
210Po in hair is available. However, it is not obvious to
assess the intake and level of
210Po in the body from hair
measurements because their results are highly dependent on
modality of sample collection and because the model does
not discriminate between excretion into sweat and hair. In
the ﬁrst few days after incorporation, the amount of
210Po
excreted in urine is markedly higher than that in hair and
sweat (of a factor up to 25 times). This factor is predicted to
be smaller at later times, reaching about the value of 1
approximately 100 days after intake.
By using the ICRP model, the predicted daily
urinary excretions of
210Po for members of the public are
1.1 · 10
–3 Bq d
–1 on the ﬁrst day, 2.0 · 10
–3 Bq d
–1 on
the 10th day, 1.3 · 10
–3 Bq d
–1 on the 30th day and
3.6 · 10
–4 Bq d
–1 on the 100th day after acute ingestion
of 1 Bq of
210Po; and 1.0 · 10
–4, 1.9 · 10
–4, 1.7 · 10
–4
and 8.3 · 10
–5 Bq d
–1 on same mentioned days after acute
inhalation, respectively.
210Po dose conversion factor of daily urinary excretion
to effective dose
To enable an easy calculation of the effective dose for the
persons whose urinary excretion were measured, the daily
urinary excretion to effective dose conversion factor were
calculated based on the ICRP and L&E models. They are
tabulated in Table 2. There are two kinds of conversion
factors presented in Table 2, namely, E/U and E’/U, where
E is the effective dose coefﬁcient, as deﬁned and recom-
mended by ICRP; E’ is the effective dose by the time T
after intakes. In the earlier days, the factor E/U is larger
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Fig. 2 Time-dependence of organ equivalent dose and effective dose
coefﬁcient after acute ingestion and inhalation for members of the
public and the workers by using the systemic models recommended
by ICRP [12] and the model developed recently by Leggett and
Eckerman (L&E) [15], combining the gastrointestinal tract and the
human respiratory tract models [16, 17]. The line legend symbols,
which are shown in the ﬁgure, are applicable for the others. The title
of ‘‘ICRP Public/Workers Ingestion/Inhalation’’ represents the ICRP
model for members of the public/the workers by ingestion/inhalation
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123than E’/U, however, after 300 days from intake, those two
factors reach the same value. For example, if one has
inhaled 1 Bq of
210Po, according to the ICRP model for
members of the public, the resulting effective dose E’ is
1.4 · 10
–7 by T = 1 day, 2.0 · 10
–6 by T = 30 days and
3.3 · 10
–6 Sv Bq
–1 by T = 50 years. The effective dose E’
released at the time of urine collection can be estimated. It
represents approximately the lower limits of dose released
by
210Po in the earlier days. Since measurements were
generally conducted few days after sampling, the results of
the activity measurements in urine needed to be corrected
for radioactive decay in order to obtain the actual activity
value at the day of urine collection.
210Po body content and urinary and fecal excretion for
normal unexposed people
According to the average concentration of
210Po in the
foodstuffs and in the air reported by UNSCEAR [2], the
normal unexposed person ingests 0.16 Bq and inhales
1 mBq of
210Po each day. Applying the ICRP model for
members of the public, the content of
210Po in human body
is predicted to be about 1.1 Bq. It is estimated that about
4 mBq in urine and 0.15 Bq in feces could be found daily.
These results are in excellent agreement with the experi-
mental values reported in the literature [6–11, 22, 23].
Internal dose assessment for the monitored subjects
Although the measured excreted activities were compara-
ble to the natural levels, and below the threshold set by the
HPA to identify individuals probably exposed to
210Po
from the London incident [22], effective doses were
nonetheless calculated under the pessimistic assumption
that the measured activities were actually due to an acute
intake on the day of suspected exposure to
210Po. In
Table 1 the values of committed effective dose E (over
50 years) and E0 (till the day of sample collection) are
presented as estimated from the results of the measure-
ments in urine. The intakes of inhalation and ingestion
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Fig. 3 Time-dependence of mean organ absorbed dose after acute
ingestion and inhalation for members of the public and the workers by
using the systemic models recommended by ICRP [12] and the model
developed recently by Leggett and Eckerman (L&E) [15], combining
the gastrointestinal tract and the human respiratory tract models [16,
17]. The line legend symbols, which are shown in the ﬁgure, are
applicable for the others. The title of ‘‘ICRP Public/Workers
Ingestion/Inhalation’’ represents the ICRP model for members of
the public/the workers by ingestion/inhalation
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123were assumed separately. As samples were collected only
few days after the suspected exposure, the estimate of the
effective dose E0 is much lower than the value of E.
Considering the values of E as conservative estimates of
the exposures of the monitored subjects, it can be seen that
the resulting effective doses range from 2.1 · 10
–3 to
1.7 · 10
–2 mSv by ingestion, and from 5.5 · 10
–2 to
4.5 · 10
–1 mSv by inhalation. Even under the very
restrictive and pessimistic assumptions used for these
evaluations, the dose received would be considered to
represent the natural background radiation dose contributed
from
210Po.
Estimating
210Po intake for Mr. Alexander Litvinenko
As reported in the media, Mr. Litvinenko was most pos-
sibly poisoned on 1 November 2006 and died 23 days later
on 23 November at 21:21 o’clock. From the available
information, it is possible to assume that polonium was
administered orally, and that multiple organ failure, prob-
ably connected with bone marrow syndrome, was
responsible for the death of Mr. Litvinenko.
As Harrison et al. [24] pointed out, animal studies
showed that multiple organ damages were the cause of
deaths within few weeks from intake of
210Po. The results
of the biokinetic modeling presented above indicated that
kidneys, liver and red marrow could be the critical organs,
being among the organs with the highest absorbed dose
coefﬁcients. According to the data presented by Harrison
et al. [24], the lethal dose LD50 may be estimated as about
3–4 Gy for the bone marrow syndrome, 6 Gy for acute
kidneys damage and 8 Gy for acute liver damage. An
LD100 of 5 Gy for red marrow syndrome is also given.
Those values were calculated for internal irradiation from
210Po, taking into account relative biological effectiveness
(RBE) of alpha particles and dose protraction. The absor-
bed dose of 5 Gy to red marrow, 6 Gy to kidneys and 8 Gy
to liver were applied as a basis on the organ lethal dose in
this work to estimate the possible intake of
210Po by Mr.
Litvinenko.
The organ absorbed dose coefﬁcients were calculated for
day 23afteringestion(thedayof23Novemberwasincluded
as full day in the calculations) in the present work. The
resulting dose coefﬁcients are 4.6 · 10
–2 (1.8 · 10
–2)G y
MBq
–1 for red bone marrow, 2.2 · 10
–1 (1.3 · 10
–1)
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Fig. 4 Daily urinary and fecal excretions for members of the public
and the workers after acute ingestion and inhalation of 1 Bq of
210Po
by using the systemic models recommended by ICRP [12] and the
model developed recently by Leggett and Eckerman [15], coupled
with the gastrointestinal tract and the human respiratory tract models
[16, 17]
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123Gy MBq
–1 for kidneys, 1.1 · 10
–1 (8.5 · 10
–2) Gy MBq
–1
for liver with ICRP (L&E) model, assuming an f1 value of
0.5; and 9.2 · 10
–3 (3.6 · 10
–3) Gy MBq
–1 for red bone
marrow, 4.4 · 10
–2 (2.6 · 10
–2)G y B q
–1 for kidneys,
2.3 · 10
–2 (1.7 · 10
–2) Gy MBq
–1 for liver assuming an f1
value of 0.1.
The estimation of possible intake of
210Po is summa-
rized in Table 3. Both of the ICRP and L&E models were
used. According to different f1 values of 0.5 and 0.1, the
estimated amounts of
210Po range from 27 to 1,408 MBq,
corresponding to 0.2 to 8.5 lg. Moreover, the organ
absorbed doses, calculated after an incorporation of esti-
mated amount of
210Po assuming the red bone marrow as a
critical organ with an absorbed dose of 5 Gy, are presented
in Table 4. In their paper, Harrison et al. [24] concluded
that 0.1–0.3 GBq or more absorbed to blood of an adult
male is likely to be fatal within 1 month. This range would
correspond to an intake of 200–600 MBq assuming 50%
absorption to blood and to 1–3 GBq assuming 10%
absorption to blood, respectively. These values are con-
sistent with the estimates obtained in the present work.
Conclusions
In this work, the time-dependent organ equivalent dose,
effective dose and daily excretion in urine and in feces after
an acute intake of
210Po are calculated by applying the
models of polonium recommended by ICRP and the new
model developed recently by Leggett and Eckerman. The
Table 2 Daily urinary excretion to effective dose conversion factor (mSv per mBq d
–1) for adult members of the public
Dt (day) Ingestion Inhalation
ICRP model L&E model ICRP model L&E model
E/UE 0/UE /UE 0/UE /UE 0/UE /UE 0/U
1 1.1E – 03 1.6E – 05 5.6E – 04 7.6E – 06 3.3E – 02 1.4E – 03 1.5E – 02 6.4E –0 4
3 5.4E – 04 2.8E – 05 5.2E – 04 2.2E – 05 1.6E – 02 1.8E – 03 1.4E – 02 1.5E –0 3
5 5.6E – 04 4.9E – 05 6.1E – 04 4.3E – 05 1.6E – 02 2.7E – 03 1.6E – 02 2.6E –0 3
7 5.9E – 04 7.0E – 05 7.1E – 04 6.8E – 05 1.7E – 02 3.6E – 03 1.8E – 02 3.8E –0 3
10 6.2E – 04 1.0E – 04 8.5E – 04 1.1E – 04 1.7E – 02 4.9E – 03 2.0E – 02 5.7E –0 3
13 6.6E – 04 1.4E – 04 9.9E – 04 1.7E – 04 1.7E – 02 6.1E – 03 2.2E – 02 7.7E –0 3
15 6.8E – 04 1.7E – 04 1.1E – 03 2.1E – 04 1.7E – 02 6.9E – 03 2.3E – 02 8.9E –0 3
17 7.1E – 04 1.9E – 04 1.2E – 03 2.5E – 04 1.8E – 02 7.6E – 03 2.4E – 02 1.0E –0 2
20 7.5E – 04 2.3E – 04 1.3E – 03 3.2E – 04 1.8E – 02 8.7E – 03 2.5E – 02 1.2E –0 2
21 7.6E – 04 2.5E – 04 1.3E – 03 3.5E – 04 1.8E – 02 9.0E – 03 2.6E – 02 1.3E –0 2
22 7.8E – 04 2.6E – 04 1.4E – 03 3.7E – 04 1.8E – 02 9.4E – 03 2.6E – 02 1.3E –0 2
23 7.9E – 04 2.8E – 04 1.4E – 03 4.0E – 04 1.8E – 02 9.7E – 03 2.7E – 02 1.4E –0 2
24 8.1E – 04 2.9E – 04 1.5E – 03 4.3E – 04 1.8E – 02 1.0E – 02 2.7E – 02 1.4E –0 2
25 8.2E – 04 3.1E – 04 1.5E – 03 4.6E – 04 1.9E – 02 1.0E – 02 2.8E – 02 1.5E –0 2
30 9.1E – 04 3.9E – 04 1.7E – 03 6.1E – 04 1.9E – 02 1.2E – 02 3.0E – 02 1.8E –0 2
40 1.1E – 03 5.8E – 04 2.2E – 03 9.9E – 04 2.1E – 02 1.5E – 02 3.4E – 02 2.4E –0 2
50 1.3E – 03 8.0E – 04 2.9E – 03 1.5E – 03 2.3E – 02 1.8E – 02 3.9E – 02 2.9E –0 2
60 1.6E – 03 1.1E – 03 3.6E – 03 2.1E – 03 2.6E – 02 2.1E – 02 4.4E – 02 3.6E –0 2
70 1.9E – 03 1.4E – 03 4.6E – 03 3.0E – 03 2.8E – 02 2.4E – 02 5.0E – 02 4.2E –0 2
80 2.3E – 03 1.8E – 03 5.8E – 03 4.0E – 03 3.1E – 02 2.8E – 02 5.7E – 02 5.0E –0 2
90 2.8E – 03 2.3E – 03 7.3E – 03 5.4E – 03 3.5E – 02 3.2E – 02 6.4E – 02 5.8E –0 2
100 3.4E – 03 2.9E – 03 9.0E – 03 7.0E – 03 3.9E – 02 3.6E – 02 7.3E – 02 6.7E –0 2
200 2.2E – 02 2.2E – 02 6.7E – 02 6.5E – 02 1.2E – 01 1.2E – 01 2.4E – 01 2.3E –0 1
300 1.5E – 01 1.5E – 01 4.0E – 01 4.0E – 01 3.8E – 01 3.8E – 01 7.3E – 01 7.2E –0 1
500 6.5E + 00 6.5E + 00 1.1E + 01 1.1E + 01 3.4E + 00 3.4E + 00 6.4E + 00 6.4E +0 0
700 2.6E + 02 2.6E + 02 2.7E + 02 2.7E + 02 2.8E + 01 2.8E + 01 5.2E + 01 5.2E +0 1
1,000 6.4E + 04 6.4E + 04 3.1E + 04 3.1E + 04 6.6E + 02 6.6E + 02 1.2E + 03 1.2E +0 3
Dt denotes the time elapsed from assumed exposure to sample collection. E denotes the effective dose coefﬁcient at 50 years after intake. E0
denotes the effective dose committed till the time of sample collection. U denotes the daily urinary excretion at the time of interest. L&E model
denotes model developed by Leggett and Eckerman. For ingestion, f1 value of 0.5 is assumed. For inhalation, the absorption material of Type M,
f1 value of 0.1 and an activity median aerodynamic diameter (AMAD) of 1 lm are assumed
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123conversion factors from the daily urinary excretion to the
effective dose were evaluated. Moreover, the 24-h-urine
samples of seven persons who were possibly contaminated
were measured in the GSF Radioanalytical Laboratory.
Their measured excretions resulted within the natural level
of the excretion rate of
210Po, and below the threshold limit
value of 30 mBq d
–1 recommended by the HPA to identify
individuals probably exposed to
210Po from the London
incident. The effective dose was estimated for those seven
persons using their measured urinary excretion and the
calculated conversion factors. They were in the range of
2.1 · 10
–3 to 1.7 · 10
–2 mSv assuming an intake by
ingestion, and 5.5 · 10
–2 to 4.5 · 10
–1 mSv by inhalation.
They are much lower than the mean effective dose of
2.4 mSv to the population in the federal republic of
Germany during the year 2005 [25]. From the fact that the
measured results were within the natural level of the
excretion rate of
210Po, it is concluded that no additional
210Po intake can be detected. Thus, no excess health effects
related to the toxicity of
210Po are expected for those
monitored subjects besides the background exposure to the
natural level of
210Po. In addition, the time-dependent mean
organ absorbed dose was calculated with the ICRP and L&E
models. Based on these calculated organ absorbed doses,
and different assumptions on lethal absorbed doses for red
bone marrow, kidneys, liver, and on blood absorption, the
minimum estimated amount of
210Po which led to the death
of Mr. Alexander Litvinenko in November 2006 in London
is estimated to range from 27 to 1,408 MBq, about 0.2 to
8.5 lg, if only
210Po was used as a poison.
Table 3 Possible incorporation of
210Po estimated for Mr. Alexander Litvinenko using the biokinetic models of ICRP [12] and L&E [15] with
the assumption of different damaged organ and the lethal absorbed dose
Red bone marrow
a
(5 Gy
b)
Kidneys
a
(6 Gy
b)
Liver
a
(8 Gy
b)
Biokinetic model ICRP L&E ICRP L&E ICRP L&E ICRP L&E ICRP L&E ICRP L&E
f1 Value 0.1 0.1 0.5 0.5 0.1 0.1 0.5 0.5 0.1 0.1 0.5 0.5
Estimated intake
(MBq) 546 1,408 109 281 136 230 27 46 351 473 70 94
(lg) 3.3 8.5 0.7 1.7 0.8 1.4 0.2 0.3 2.1 2.9 0.4 0.6
a Critical organ
b Lethal absorbed dose
Table 4 Estimated incorporation and organ absorbed doses based on different assumptions of lethal red bone marrow dose of 5 Gy with f1
values of 50 and 10% for blood absorption
Assumption #1
a #2
b #3
c #4
d #5
e #6
f #7
g #8
h
Intake
(lg) 0.7 1.7 2.4 2.4 3.3 8.5 12.0 12.0
(MBq) 109 281 400 400 546 1,408 2,000 2,000
Bone surface (Gy) 3.0 18.3 11.1 26.0 3.0 18.3 11.1 26.0
Stomach (Gy) 0.6 1.8 2.0 2.5 0.6 1.8 2.1 2.6
Small intestine (Gy) 0.6 1.8 2.0 2.5 0.6 1.9 2.3 2.7
Colon (Gy) 0.7 2.0 2.4 2.9 1.4 3.9 5.1 5.6
Kidneys (Gy) 24.1 36.8 88.4 52.4 24.0 36.8 88.0 52.2
Liver (Gy) 12.4 23.9 45.6 34.0 12.5 23.8 45.6 33.8
Red bone marrow (Gy) 5.0 5.0 18.4 7.1 5.0 5.0 18.3 7.1
Spleen (Gy) 20.7 15.3 76.0 21.8 20.7 15.2 75.8 21.6
a Lethal red bone marrow dose 5 Gy using ICRP model with f1 = 0.5
b Lethal red bone marrow dose 5 Gy using L&E model with f1 = 0.5
c 0.4 GBq ingestion using ICRP model with f1 = 0.5
d 0.4 GBq ingestion using L&E model with f1 = 0.5
e Lethal red bone marrow dose 5 Gy using ICRP model with f1 = 0.1
f Lethal red bone marrow dose 5 Gy using L&E model with f1 = 0.1
g 2 GBq ingestion using ICRP model with f1 = 0.1
h 2 GBq ingestion using L&E model with f1 = 0.1
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